Coverage of preventative and screening interventions
In many low- and middle-income settings, recommended packages of ANC are already standard of care according to national policy, but recommended evidence-based interventions still fail to reach every pregnant woman [
3,
4,
33,
34]. We investigated rates of coverage for ANC interventions related to prevention, screening, and birth preparedness among our GN sites.
Detection, prevention, and treatment of syphilis may be one of the highest impact interventions available for prevention of stillbirth;[
35,
36] as such, syphilis screening during pregnancy is a key intervention for prevention of poor pregnancy outcomes [
37‐
40]. It was thus discouraging to find that, only about half of all women (excluding Pakistan) reported having been tested for syphilis during their most recent pregnancy. Results from the site in Belgaum, India, were particularly interesting, in that the low rates of reported syphilis testing (only 19% of women) were atypical as compared to this site’s high performance on other ANC indicators. While this may, in part, reflect dropping prevalence of maternal and congenital syphilis within the Indian setting [
37], it does not entirely explain why syphilis screening rates were much higher in the site in Nagpur, India compared to the Belgaum, India site.
HIV screening during pregnancy is essential in order to identify HIV-infected women, and link them to strategies for prevention of mother-to-child transmission of HIV [
41]. It was encouraging to observe high rates of HIV testing overall, with the exception of the Guatemalan site, in which only a little over half of all women reported being tested for HIV.
Neonatal tetanus also remains a profound risk to newborn health in resource-limited regions, particularly sub-Saharan Africa, and is best prevented by maternal tetanus immunization [
42‐
44]. The rate for at least one injection of tetanus toxoid was 88% for the GN overall, with very high coverage rates (above 93%) observed in the sites in Africa, India, and Argentina. Similar to other indicators, low rates of coverage for this preventative intervention were observed in the Pakistan site [
45,
46]. We did not collect information regarding how many doses of tetanus toxoid women received, so it is unknown to what extent there was complete coverage for prevention of maternal/neonatal tetanus at the GN sites, even among the 88% of pregnant women who reported receiving an injection.
Anemia during pregnancy is related to a number of poor pregnancy outcomes for mothers and newborns, and of particular concern in malarial endemic areas of the world [
47,
48]; thus, hemoglobin assessment and supplementation during pregnancy with prenatal vitamins and iron are key ANC recommendations at all GN sites [
43]. We detected large variability in rates of screening for anemia, with coverage ranging from virtually none in the sites in Guatemala and Pakistan to nearly 100% in Nagpur, India. In Kenya and Zambia, where malaria, helminthic infection, and iron-deficiency anemia are prevalent, [
47,
49,
50] lower than desired levels of coverage for hemoglobin testing were observed. Encouragingly, the vast majority of women did report obtaining prenatal vitamins/iron supplementation during pregnancy. We did not collect information regarding for how long, or when, women took prenatal vitamins/iron, so it is not possible to assess whether women received 90 days of iron-folate supplementation as is recommended in some contexts [
51] or if the consumption of prenatal vitamins/iron was continuous, intermittent, or some combination thereof [
52].
Variable rates of syphilis and HIV screening, hemoglobin testing, and tetanus toxoid vaccination that were observed in this study may, in part, reflect different priorities of national governments, based on variable prevalence rates of sexually transmitted infections among pregnant women in different global regions [
44,
53‐
55], or be influenced by the relative availability of resources for immunization and/or blood testing (education and training of health workers; community sensitization; supply chain logistics) [
56,
57]. Cultural barriers, fear, stigma, and resistance to some interventions in general, or among pregnant women in particular, also exist in some settings, and has been cited as impacting screening rates for sexually transmitted infections and tetanus toxoid vaccination efforts [
58]. Other contributing factors to site or regional differences for coverage of particular interventions, including iron/folate supplements, may include: lack of knowledge among pregnant women as to the deleterious health impact and/or importance of screening for conditions such as syphilis, tetanus, or anemia [
29,
59,
60]; late initiation of, and infrequent utilization of ANC; and perceived or actual financial barriers associated with obtaining interventions [
61].
It is unclear if, or in what manner, the selected location and/or provider for ANC may have impacted quality of ANC, or contributed to gaps in coverage of key interventions. However, in our study, 73% of women in the Pakistani site reported using private clinics for ANC. Majrooh and colleagues recently noted that in Pakistan, private clinics, in particular, “are unable to provide the essential laboratory services package included in the standard ANC protocol,” [
8]. Similarly, 38% of Guatemalan women reported seeking ANC from TBAs. Within the Guatemalan setting, TBAs are generally not equipped with the knowledge, skills, or materials to perform blood-based testing procedures, nor do they have access to laboratory support [
62]. Lack of equipment was likely one key factor underlying poor coverage for maternal height assessment in Kenya, as most government facilities do not have stadiometers.
For the Argentina site in particular, higher rates of tetanus toxoid vaccination, prenatal vitamin supplementation, and syphilis and HIV testing may be due in part to women desiring technically advanced ANC, and actively seeking medical interventions from well-equipped government facilities [
63]. Reasons for less than half of Argentinian women receiving hemoglobin screening are less clear.
Birth preparedness
Access to skilled birth attendants and care during delivery saves maternal and newborn lives [
64]; preparing a birth plan and planning for emergencies during the antenatal period can improve women’s willingness to seek skilled care at delivery [
65]. We assessed the frequency with which women: (a) reported having prepared an emergency/ hospitalization fund; (b) identified transport options prior to delivery; (c) identified a birth attendant prior to delivery; and (d) whether or not the identified birth attendant was present at the delivery. In general, for the first three birth plan components, the Asian sites (India and Pakistan) reported the highest coverage levels. The Guatemalan and Zambian sites reported the highest numbers of women for whom the birth attendant they identified prior to delivery actually attended the birth. In Guatemala, this result may be linked with a greater proportion of women also receiving care from TBAs. In Zambia, while 60% of respondents most frequently sought ANC at a government hospital or clinic, 35% of women received ANC from “other” (not TBA). It is unclear if, or how, this may have impacted patterns of ANC access and coverage of ANC interventions.
Because of the large quantity of data regarding the quality indicators, we developed a simple grading system to provide an overall site assessment regarding the delivery of a comprehensive package of ANC at each location. We realize the categories used and the cutoffs for classification are arbitrary. Nevertheless, Figure
3 provides a visual assessment of the quality/quantity of ANC at the individual sites. The overall poor result for Pakistan in particular may explain, in part very high mortality rates reported at this site in another paper in this series [
66]. We hope that by assessing the quality/quantity of both: (a) individual ANC components and (b) delivery of the overall ANC package within and between sites, this will assist stakeholders to identify targets which lead to improvements in both individual and bundled ANC indicators over time.
The strengths of our study include the population based prospective nature of the data collection, large sample size, and the quality of the MNHR in regards to high consent rates, low loss-to-follow up rates, and overall data quality [
13‐
15,
67]. We collected information about a wide variety of global indicators for ANC access and coverage. However, some ANC indicators of specific regional interest, such as those related to detection and prevention of malaria in pregnancy, were not assessed.
Limitations include that ANC registry data are collected primarily through maternal or birth attendant report and may reflect recall bias. Some overall results should be interpreted cautiously, since a large proportion of our sample is from the study sites in Asia, as compared to other global regions which compose the MNHR. Our study catchment areas are predominately rural clusters in confined regions of six countries, and as such, the results may not be representative of patterns from urban settings, in particular, or entire national or global regions, in general.
However, this latter concern is somewhat attenuated by the fact that, for the most part, our results align with those reported from recent National Household and/or Demographic and Health Surveys (DHS) [
46]. One strength of our data, as compared to that generated by national DHS, is that the MNHR results provide a long-term picture of patterns of ANC access and quality of coverage over time, whereas large national surveys provide limited snapshots.